![Pierandrea Muglia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 387 817 $ al 31/07/2026
Pierandrea Muglia is the founder of GRIN Therapeutics, Inc. Currently, Dr. Muglia is Chief Executive Officer at Ichnos SRL and Chief Medical Officer at Saniona AB starting in 2023.
Formerly, Dr. Muglia was Vice President & Head-Experimental Medicine at NTG Nordic Transport Group A, Chief Marketing Officer at Handl Therapeutics BV, and Vice President at UCB Pharma SA (Belgium) from 2012 to 2019.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SANIONA AB 0,19 % | 31/12/2024 | 259.999 ( 0,19 % ) | 387 817 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SANA AB | Director Técnico/Científico/I+D | 10/03/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
GRIN Therapeutics, Inc.
 GRIN Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of precision therapeutics for pediatric neurodevelopmental disorders | Fundador | 01/09/2022 |
UCB Pharma SA (Belgium)
 UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01/10/2019 |
Handl Therapeutics BV
 Handl Therapeutics BV BiotechnologyHealth Technology Provides gene therapy treatment solutions | Ventas & Marketing | - |
| NTG NORDIC TRANSPORT GROUP A/S | Director/Miembro de la Junta | 28/05/2010 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
NTG Nordic Transport Group A/S
 NTG Nordic Transport Group A/S TruckingTransportation Transports goods through truck, ship and aircraft | Transportation |
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Saniona AB
 Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Handl Therapeutics BV
Handl Therapeutics BV BiotechnologyHealth Technology Provides gene therapy treatment solutions | Health Technology |
GRIN Therapeutics, Inc.
GRIN Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of precision therapeutics for pediatric neurodevelopmental disorders | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
